Cargando…
The combined expression of Semaphorin4D and PlexinB1 predicts disease recurrence in colorectal cancer
BACKGROUND: Binding to Sema4D and PlexinB1 induce angiogenesis and invasive growth in colorectal cancer (CRC). The expression of Semaphorin4D (Sema4D) and PlexinB1 has been shown to be related to the prognosis of patients with various malignancies. However, the correlation between the expression of...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4960918/ https://www.ncbi.nlm.nih.gov/pubmed/27456345 http://dx.doi.org/10.1186/s12885-016-2577-6 |
_version_ | 1782444612727603200 |
---|---|
author | Ikeya, Tetsuro Maeda, Kiyoshi Nagahara, Hisashi Shibutani, Masatsune Iseki, Yasuhito Hirakawa, Kosei |
author_facet | Ikeya, Tetsuro Maeda, Kiyoshi Nagahara, Hisashi Shibutani, Masatsune Iseki, Yasuhito Hirakawa, Kosei |
author_sort | Ikeya, Tetsuro |
collection | PubMed |
description | BACKGROUND: Binding to Sema4D and PlexinB1 induce angiogenesis and invasive growth in colorectal cancer (CRC). The expression of Semaphorin4D (Sema4D) and PlexinB1 has been shown to be related to the prognosis of patients with various malignancies. However, the correlation between the expression of Sema4D and PlexinB1 and the relapse-free survival in patients with colorectal cancer remains controversial. METHODS: The study population included patients who underwent surgery for colorectal cancer (n = 226). The expression of Sema4D and PlexinB1 were analyzed by immunohistochemistry in tissue of stage I, II, and III colon cancers. RESULTS: The immunohistochemical staining of colorectal cancer tissue specimens revealed that 95 (42 %) and 105 (46.4 %) of the specimens were positive for Sema4D and PlexinB1. The expression of Sema4D and PlexinB1 respectively were both found to be significantly related to stage, depth of tumor invasion, lymph node metastasis, lymphatic invasion, and venous invasion, respectively. Sixty-three patients (27.9 %) expressed both Sema4D and PlexinB1. The positive expression of both Sema4D and PlexinB1 was found to be an independent risk factor for a worse survival (HR 1.079, CI 1.013–2.868; P = 0.044). CONCLUSION: The combination of Sema4D and PlexinB1 protein detected by immunohistochemistry was therefore useful for predicting disease recurrence in CRC patients. |
format | Online Article Text |
id | pubmed-4960918 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-49609182016-07-27 The combined expression of Semaphorin4D and PlexinB1 predicts disease recurrence in colorectal cancer Ikeya, Tetsuro Maeda, Kiyoshi Nagahara, Hisashi Shibutani, Masatsune Iseki, Yasuhito Hirakawa, Kosei BMC Cancer Research Article BACKGROUND: Binding to Sema4D and PlexinB1 induce angiogenesis and invasive growth in colorectal cancer (CRC). The expression of Semaphorin4D (Sema4D) and PlexinB1 has been shown to be related to the prognosis of patients with various malignancies. However, the correlation between the expression of Sema4D and PlexinB1 and the relapse-free survival in patients with colorectal cancer remains controversial. METHODS: The study population included patients who underwent surgery for colorectal cancer (n = 226). The expression of Sema4D and PlexinB1 were analyzed by immunohistochemistry in tissue of stage I, II, and III colon cancers. RESULTS: The immunohistochemical staining of colorectal cancer tissue specimens revealed that 95 (42 %) and 105 (46.4 %) of the specimens were positive for Sema4D and PlexinB1. The expression of Sema4D and PlexinB1 respectively were both found to be significantly related to stage, depth of tumor invasion, lymph node metastasis, lymphatic invasion, and venous invasion, respectively. Sixty-three patients (27.9 %) expressed both Sema4D and PlexinB1. The positive expression of both Sema4D and PlexinB1 was found to be an independent risk factor for a worse survival (HR 1.079, CI 1.013–2.868; P = 0.044). CONCLUSION: The combination of Sema4D and PlexinB1 protein detected by immunohistochemistry was therefore useful for predicting disease recurrence in CRC patients. BioMed Central 2016-07-25 /pmc/articles/PMC4960918/ /pubmed/27456345 http://dx.doi.org/10.1186/s12885-016-2577-6 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Ikeya, Tetsuro Maeda, Kiyoshi Nagahara, Hisashi Shibutani, Masatsune Iseki, Yasuhito Hirakawa, Kosei The combined expression of Semaphorin4D and PlexinB1 predicts disease recurrence in colorectal cancer |
title | The combined expression of Semaphorin4D and PlexinB1 predicts disease recurrence in colorectal cancer |
title_full | The combined expression of Semaphorin4D and PlexinB1 predicts disease recurrence in colorectal cancer |
title_fullStr | The combined expression of Semaphorin4D and PlexinB1 predicts disease recurrence in colorectal cancer |
title_full_unstemmed | The combined expression of Semaphorin4D and PlexinB1 predicts disease recurrence in colorectal cancer |
title_short | The combined expression of Semaphorin4D and PlexinB1 predicts disease recurrence in colorectal cancer |
title_sort | combined expression of semaphorin4d and plexinb1 predicts disease recurrence in colorectal cancer |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4960918/ https://www.ncbi.nlm.nih.gov/pubmed/27456345 http://dx.doi.org/10.1186/s12885-016-2577-6 |
work_keys_str_mv | AT ikeyatetsuro thecombinedexpressionofsemaphorin4dandplexinb1predictsdiseaserecurrenceincolorectalcancer AT maedakiyoshi thecombinedexpressionofsemaphorin4dandplexinb1predictsdiseaserecurrenceincolorectalcancer AT nagaharahisashi thecombinedexpressionofsemaphorin4dandplexinb1predictsdiseaserecurrenceincolorectalcancer AT shibutanimasatsune thecombinedexpressionofsemaphorin4dandplexinb1predictsdiseaserecurrenceincolorectalcancer AT isekiyasuhito thecombinedexpressionofsemaphorin4dandplexinb1predictsdiseaserecurrenceincolorectalcancer AT hirakawakosei thecombinedexpressionofsemaphorin4dandplexinb1predictsdiseaserecurrenceincolorectalcancer AT ikeyatetsuro combinedexpressionofsemaphorin4dandplexinb1predictsdiseaserecurrenceincolorectalcancer AT maedakiyoshi combinedexpressionofsemaphorin4dandplexinb1predictsdiseaserecurrenceincolorectalcancer AT nagaharahisashi combinedexpressionofsemaphorin4dandplexinb1predictsdiseaserecurrenceincolorectalcancer AT shibutanimasatsune combinedexpressionofsemaphorin4dandplexinb1predictsdiseaserecurrenceincolorectalcancer AT isekiyasuhito combinedexpressionofsemaphorin4dandplexinb1predictsdiseaserecurrenceincolorectalcancer AT hirakawakosei combinedexpressionofsemaphorin4dandplexinb1predictsdiseaserecurrenceincolorectalcancer |